National Health Investors (NYSE:NHI) Stock Rating Lowered by Zacks Research

National Health Investors (NYSE:NHI) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Thursday,Zacks.com reports.

A number of other research analysts have also recently commented on the company. BMO Capital Markets cut their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Wells Fargo & Company decreased their price target on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price objective on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Truist Financial reduced their target price on National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.86.

National Health Investors Stock Up 1.5%

Shares of NHI opened at $77.58 on Thursday. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The business has a fifty day moving average of $74.89 and a 200 day moving average of $79.64. The company has a market cap of $3.76 billion, a PE ratio of 25.02, a P/E/G ratio of 4.15 and a beta of 0.52. National Health Investors has a 52-week low of $67.94 and a 52-week high of $91.38.

National Health Investors (NYSE:NHI) last announced its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.39). The firm had revenue of $115.13 million during the quarter, compared to analysts’ expectations of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The company’s revenue was up 28.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, sell-side analysts expect that National Health Investors will post 4.87 EPS for the current year.

Insider Activity

In other National Health Investors news, CEO D. Eric Mendelsohn purchased 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was acquired at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the acquisition, the chief executive officer owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction dated Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by corporate insiders.

Institutional Trading of National Health Investors

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors during the 4th quarter worth $27,000. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors in the fourth quarter worth about $33,000. GAMMA Investing LLC raised its holdings in National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 136 shares in the last quarter. Finally, Key Capital Management INC purchased a new stake in shares of National Health Investors during the fourth quarter valued at about $47,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.